Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome
Martina Fanella(Policlinico Umberto I), Giorgio Vivacqua(Università Campus Bio-Medico), Emanuele Cerulli Irelli(Sapienza University of Rome), Fabio Di Fabio(Policlinico Umberto I), Tommaso Accinni(Sapienza University of Rome), Carlo Di Bonaventura(Sapienza University of Rome), Francesco Emanuele Bellomi(Università Campus Bio-Medico), Carolina Putotto(Sapienza University of Rome), Federica Pulvirenti(Policlinico Umberto I)
Cited by 2
Related Papers
Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome
|Epilepsia|2019|64
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
|CNS Drugs|2021|56
Perampanel as precision therapy in rare genetic epilepsies
|Epilepsia|2023|43